Advertisement covers EACS 2013

Building a Better HIV Drug: Nano-Formulated Medicines

December 18, 2013


Building a Better HIV Drug: Nano-Formulated Medicines

Antiretrovirals have turned HIV infection from a deadly disease into a manageable chronic condition. However, current treatment does have downsides, including the need for daily dosing (at minimum) and the risk for drug resistance to emerge when doses are missed.

One of the keys to the future of HIV treatment may be nano-formulations of drugs that help deliver medications in a more potent and efficient manner with a lower frequency of doses. Andrew Owen, Ph.D., from the University of Liverpool, gave a mini-lecture at EACS 2013 providing an overview and update on the topic.

Get Started

This article was provided by It is a part of the publication The 14th European AIDS Conference (EACS 2013).

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.